Menu

Radiopharm Theranostics Limited RADX

Full chart Compare
Set alert

Price alert · RADX

All alert types
0.89 USD +0.02 (+2.30%)

At closeNov 6, 2026, 7:30 AM EST

0.89 0.00 -0.31%

Pre-market · Nov 6, 7:30 AM ET

0.837 Day range 0.99
0.82 52-week range 16.25
YTD
-82.97%
1 year
-80.38%

Revenue & Expenses

Other Income → Expenses: $12.84MExpenses → Gross Loss: $2.10MExpenses → Selling, General & Admin: $15.86MExpenses → Other Operating Expenses: $48.87MIncome Tax Benefit → Expenses: $53.25KNet Loss → Expenses: $53.94MRevenue → Cost of Revenue: $2.71MOther Income$12.84MIncome Tax Benefit$53.25KNet Loss$53.94MCost of Revenue$4.81MExpenses$66.84MGross Loss$2.10MSelling, General & Admin$15.86MOther Operating Expenses$48.87MRevenue$2.71M

Latest period ending Jun 30, 2026 · select a line to chart its full history

RADX annual income statement
Fiscal yearFY 2026 Jun 30, 2026FY 2025 Jun 30, 2025FY 2024 Jun 30, 2024FY 2023 Jun 30, 2023FY 2022 Jun 30, 2022
2.77M3.63M299.23K292.36K0
263.39K39.28K299.23K292.36K0
-67.52M-48.43M-48.55M-40.55M-21.03M
-54.53M-36.24M-45.78M-35.18M-30.40M
-5.37-5.28-37.23-33.96-50.34
RADX annual balance sheet
Fiscal yearFY 2026 Jun 30, 2026FY 2025 Jun 30, 2025FY 2024 Jun 30, 2024FY 2023 Jun 30, 2023FY 2022 Jun 30, 2022
4.14M29.12M18.58M11.70M26.98M
60.13M86.48M72.04M74.95M83.38M
37.81M43.61M44.68M29.37M20.42M
25.77M32.10M33.43M23.79M18.02M
24.69M44.79M28.12M44.38M62.96M
RADX annual cash flow
Fiscal yearFY 2026 Jun 30, 2026FY 2025 Jun 30, 2025FY 2024 Jun 30, 2024FY 2023 Jun 30, 2023FY 2022 Jun 30, 2022
-52.78M-36.65M-22.98M-23.20M-9.91M
-5.42M1.77M-320.00K-1.53M-28.38M
33.37M45.43M30.20M9.22M65.11M
-24.83M10.56M6.90M-15.51M26.82M